Expert Describes the Role ctDNA Testing May Play in the Multidisciplinary Care of Colorectal Cancer
January 16th 2023An expert from Natera shares multidisciplinary takeaways from the GALAXY cohort of the CIRCULATE-Japan study, assessing circulating tumor DNA as a prognostic biomarker for resectable colorectal cancer.